Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19

Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19

Describes the cohort of patients receiving ECMO-VV or ECMO-VA in the management of severe ARDS refractory to SARS-CoV-2 in the Strasbourg and Louvain centres

Inclusion Criteria:

• Patient over the age of 18;
• Diagnostic COVID-19 by RT-PCR;
• Hospitalisation in resuscitation for the management of complications related to COVID-19
• Implanted ECMO-VV or VA during hospitalisation;
• Patient agreeing to participate in the study

Exclusion Criteria:

• Sujet who has expressed opposition to participating in the study.
• Sujet under guardianship or trusteeship
• Sujet under safeguard of justice